SCHEMBL7185340

SCHEMBL7185340

CCCCCCCCCC(=O)NS(=O)(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.57
FAAH O00519 6/20 0.55
EPHX2 P34913 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 1/20 0.52
CASP2 P42575 1/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
PPARG P37231 6/20 0.46
PPARD Q03181 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
GPR84 Q9NQS5 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21060856 1.00 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL7184916 1.00 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL11649466 1.00 HSP90AA1 (0.57) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL7180177 0.98 HSP90AA1 (0.54) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL28194397 0.96 HSP90AA1 (0.52) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL3477319 0.91 FNTA (0.46) HSP90AA1FAAHEPHX2MEN1KMT2A
Dodecanoate SCHEMBL29129545 0.84 FABP3 (0.51) HSP90AA1EPHX2CASP2CES2CES1
SCHEMBL18954224 0.83 EPHX2 (0.65) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL13188006 0.83 EPHX2 (0.65) HSP90AA1FAAHEPHX2MEN1KMT2A
SCHEMBL177558 0.82 HDAC3 (0.50) EPHX2MEN1KMT2ACASP2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US claimed
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US disclosed